Drugs / UMN-0501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00980447 | Oct → Dec 2009 | influenza | UMN Pharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UMN-0501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00980447 ↗ |
| Modality | Vaccine | “purified recombinant influenza HA vaccine (A H5N1/Vietnam/1203/2004)” NCT00980447 ↗ |